An experimental smallpox vaccine may provide a solution for U.S. health officials seeking a safe protection against biological attack for the millions of people who cannot risk the current immunization, U.S. researchers said on Wednesday. The vaccine protected monkeys against a virus related to smallpox, and created a strong immune response, the researchers reported. Past study has shown the vaccine, called Modified Vaccinia Virus Ankara, or MVA, is safe for people.
